Norges Bank purchased a new stake in shares of National Health Investors Inc (NYSE:NHI) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 490,174 shares of the real estate investment trust’s stock, valued at approximately $37,028,000. Norges Bank owned 1.15% of National Health Investors at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Eii Capital Management Inc. grew its position in National Health Investors by 3.1% during the fourth quarter. Eii Capital Management Inc. now owns 6,674 shares of the real estate investment trust’s stock valued at $504,000 after purchasing an additional 200 shares in the last quarter. Pinnacle Financial Partners Inc. grew its position in National Health Investors by 1.2% during the fourth quarter. Pinnacle Financial Partners Inc. now owns 20,670 shares of the real estate investment trust’s stock valued at $1,561,000 after purchasing an additional 250 shares in the last quarter. HL Financial Services LLC grew its position in National Health Investors by 2.1% during the fourth quarter. HL Financial Services LLC now owns 11,958 shares of the real estate investment trust’s stock valued at $903,000 after purchasing an additional 250 shares in the last quarter. State of Alaska Department of Revenue grew its position in National Health Investors by 1.9% during the fourth quarter. State of Alaska Department of Revenue now owns 13,344 shares of the real estate investment trust’s stock valued at $1,007,000 after purchasing an additional 255 shares in the last quarter. Finally, Hsbc Holdings PLC grew its position in National Health Investors by 3.7% during the fourth quarter. Hsbc Holdings PLC now owns 7,475 shares of the real estate investment trust’s stock valued at $564,000 after purchasing an additional 266 shares in the last quarter. Institutional investors and hedge funds own 71.17% of the company’s stock.
NHI stock opened at $77.55 on Tuesday. The company has a quick ratio of 17.92, a current ratio of 17.92 and a debt-to-equity ratio of 0.92. The company has a market capitalization of $3.31 billion, a price-to-earnings ratio of 14.15, a price-to-earnings-growth ratio of 3.53 and a beta of 0.51. National Health Investors Inc has a 12 month low of $65.10 and a 12 month high of $84.57.
National Health Investors (NYSE:NHI) last posted its earnings results on Tuesday, February 19th. The real estate investment trust reported $0.87 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $1.39 by ($0.52). The business had revenue of $74.00 million during the quarter, compared to the consensus estimate of $75.16 million. National Health Investors had a return on equity of 11.36% and a net margin of 52.38%. The business’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.35 earnings per share. On average, equities research analysts predict that National Health Investors Inc will post 5.48 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, March 29th will be given a $1.05 dividend. This represents a $4.20 annualized dividend and a yield of 5.42%. This is an increase from National Health Investors’s previous quarterly dividend of $1.00. The ex-dividend date of this dividend is Thursday, March 28th. National Health Investors’s payout ratio is currently 76.64%.
NHI has been the topic of a number of research analyst reports. Zacks Investment Research raised shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Wednesday, March 6th. ValuEngine downgraded shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Monday, April 1st. Finally, SunTrust Banks boosted their price objective on shares of National Health Investors to $85.00 and gave the company a “neutral” rating in a research report on Wednesday, February 20th. They noted that the move was a valuation call. Two research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $78.14.
In other National Health Investors news, Director Robert A. Mccabe, Jr. sold 1,181 shares of the business’s stock in a transaction that occurred on Thursday, February 21st. The shares were sold at an average price of $78.04, for a total value of $92,165.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 5.11% of the company’s stock.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
See Also: Mutual Funds
Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors Inc (NYSE:NHI).
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.